Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Kimura; Tomio
Address:
Ube, JP
No. of patents:
13
Patents:












Patent Number Title Of Patent Date Issued
6063782 Pyrrolopyridazine derivatives May 16, 2000
Pyrrolopyridazine derivatives having the general formula. ##STR1## In the above formula, R.sup.1 represents a C.sub.2 -C.sub.6 alkenyl-group, a halogeno-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.6 -C.sub.10 aryl-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.2 -C.sub.6 alkynyl group, a
5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv ag November 18, 1997
Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a
5519016 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV a May 21, 1996
Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a
5496951 4-oxoquinoline-3-carboxylic acid derivatives their preparation and their use March 5, 1996
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy: R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5436367 Intermediates for certain 4-oxoquinoline-3-carboxylic acid derivatives July 25, 1995
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood plat July 25, 1995
Compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.su
5348961 4-oxoquinoline-3-carboxylic acid derivatives and their use September 20, 1994
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and February 22, 1994
Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.s
5073556 4-oxoquinoline-3-carboxylic acid derivatives and their use December 17, 1991
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
4997943 Quinoline-3-carboxylic acid derivatives March 5, 1991
Compounds of formula (I): ##STR1## (in which R.sup.1 is alkoxy, R is alkyl, haloalkyl, alkylamino, cycloalkyl or optionally substituted phenyl, X is chlorine or fluorine and Y is selected from certain specific heterocycles) have excellent antibacterial activity. They may be prepa
4749704 Cyclopenta[d]pyrimidine derivatives and use as antidepressants June 7, 1988
Compounds of formula (I): ##STR1## (wherein R.sup.1 and R.sup.2 are hydroxy, alkoxy, aryloxy or acyloxy or R.sup.2 is hydrogen, R.sup.3 is hydrogen or alkyl and R.sup.4 and R.sup.5 are hydrogen or various organic substituents) have valuable antidepressant activity and may be used
4497957 Process for preparing optically active tryptophans February 5, 1985
Biochemical optical resolution of DL-tryptophans in which DL-tryptophan amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-Tryptophan amides in racemic DL-tryptophan amides are asymmetrically hyd
4443548 Process for preparing L-.alpha.-methylphenyl alanines April 17, 1984
Biochemical optical resolution of DL-.alpha.-methylphenyl alanines in which DL-.alpha.-methylphenyl alanine amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-.alpha.-methylphenyl alanines having the










 
 
  Recently Added Patents
Controlling access to resources on a network
Method and system for determining a suppression factor of a suppression system and a lithographic apparatus
Collaborative computing community role mapping system and method
Method and system for remapping processing elements in a pipeline of a graphics processing unit
Light emitting device and light emitting device package
Electrical connector
Circuit board having semiconductor chip embedded therein
  Randomly Featured Patents
Electronic circuit with a memory matrix that stores pages including extra data
CMOS active pixel cell with self reset for improved dynamic range
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Method for allocating tire pressure control devices to wheel positions in a tire pressure control system of a motor vehicle
Polycarbonate composition
Coating substrates
Semiconductor manufacturing system, controller, semiconductor manufacturing system control method, and processing liquid collection method
Method for simultaneously preparing pharmacy vial label and drug-specific warning labels
Method for fabricating a semiconductor device
Methods, media, and mobile devices for providing information associated with a visual code